Fusion Finance Limited (NSE:FUSION)

Verve Therapeutics Revenue

In the fiscal year ending March 31, 2025, Fusion Finance had annual revenue of -3.44B INR, down -127.68%. Fusion Finance had revenue of 517.20M in the quarter ending March 31, 2025, a decrease of -84.96%.

• Revenue: -3.44B
• Revenue Growth: -127.68%
• P/S Ratio: -7.49
• Revenue / Employee: -225.02K
• Employees: 15,274
• Market Cap: 25.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	-3.44B	-15.85B	-127.68%
Mar 31, 2024	12.42B	3.02B	32.18%
Mar 31, 2023	9.40B	6.05B	181.17%
Mar 31, 2022	3.34B	576.39M	20.85%
Mar 31, 2021	2.77B	-223.45M	-7.48%